In breast cancer, radiotherapy triggers the PERK-pathway of the UPR, and this is induced by increased PERK protein levels, phosphorylated eIF2α, ATF4, and LAMP3 [140]. This evidence concerns the gene EIF2AK3 and breast cancer.